Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 23337848)

1.

A polymorphism in the protein kinase C gene PRKCB is associated with α2-adrenoceptor-mediated vasoconstriction.

Posti JP, Salo P, Ruohonen S, Valve L, Muszkat M, Sofowora GG, Kurnik D, Stein CM, Perola M, Scheinin M, Snapir A.

Pharmacogenet Genomics. 2013 Mar;23(3):127-34. doi: 10.1097/FPC.0b013e32835d247f.

2.

Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction.

Adefurin A, Ghimire LV, Kohli U, Muszkat M, Sofowora GG, Li C, Paranjape SY, Stein CM, Kurnik D.

Pharmacogenomics J. 2014 Nov 25. doi: 10.1038/tpj.2014.69. [Epub ahead of print]

PMID:
25421140
3.

Locally injected dexmedetomidine inhibits carrageenin-induced inflammatory responses in the injected region.

Sukegawa S, Higuchi H, Inoue M, Nagatsuka H, Maeda S, Miyawaki T.

Anesth Analg. 2014 Feb;118(2):473-80. doi: 10.1213/ANE.0000000000000060.

PMID:
24445644
4.

Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion.

Bell MT, Puskas F, Bennett DT, Herson PS, Quillinan N, Fullerton DA, Reece TB.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):500-6. doi: 10.1016/j.jtcvs.2013.07.043. Epub 2013 Sep 13.

PMID:
24035379
5.

Variation in the α(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose.

Ghimire LV, Muszkat M, Sofowora GG, Scheinin M, Wood AJ, Stein CM, Kurnik D.

Pharmacogenet Genomics. 2013 Sep;23(9):479-86. doi: 10.1097/FPC.0b013e3283642f93.

6.

Role of α2-adrenoceptors in electrical field stimulation-induced contraction of pig nasal mucosa and pharmacologic characterization of a novel α2C-adrenoceptor agonist.

Corboz MR, Rivelli MA, Shah H, Boyce CW, McCormick KD, Chapman RW, Hunter JC.

Am J Rhinol Allergy. 2013 Mar-Apr;27(2):84-90. doi: 10.2500/ajra.2013.27.3842.

PMID:
23562194
7.

Blacks have a greater sensitivity to α1-adrenoceptor-mediated venoconstriction compared with whites.

Adefurin A, Ghimire LV, Kohli U, Muszkat M, Sofowora GG, Paranjape SY, Stein CM, Kurnik D.

Hypertension. 2013 Apr;61(4):915-20. doi: 10.1161/HYPERTENSIONAHA.111.00854. Epub 2013 Feb 11.

8.

Alpha2C-adrenoceptors play a prominent role in sympathetic constriction of porcine pulmonary arteries.

Jantschak F, Pertz HH.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Jun;385(6):595-603. doi: 10.1007/s00210-012-0741-3. Epub 2012 Feb 28.

PMID:
22371269
9.

Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by α2 adrenoceptor agonist dexmedetomidine.

Chiu KM, Lin TY, Lu CW, Wang SJ.

Eur J Pharmacol. 2011 Nov 16;670(1):137-47. doi: 10.1016/j.ejphar.2011.08.012. Epub 2011 Sep 2.

PMID:
21914443
10.

Dorsal hand vein responses to the α₁-adrenoceptor agonist phenylephrine do not predict responses to the α₂-adrenoceptor agonist dexmedetomidine.

Posti JP, Valve L, Ruohonen S, Akkila J, Scheinin M, Snapir A.

Eur J Pharmacol. 2011 Feb 25;653(1-3):70-4. doi: 10.1016/j.ejphar.2010.11.024. Epub 2010 Dec 11.

PMID:
21147097
11.

The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery.

Yağar S, Yavaş S, Karahalil B.

Mol Biol Rep. 2011 Jun;38(5):3383-9. doi: 10.1007/s11033-010-0446-y. Epub 2010 Nov 23.

PMID:
21104443
12.

Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo.

Muszkat M, Kurnik D, Sofowora GG, Wood AJ, Stein CM.

J Hypertens. 2011 Feb;29(2):251-6. doi: 10.1097/HJH.0b013e3283407ffd.

13.

Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype.

Muszkat M, Kurnik D, Sofowora GG, Solus J, Xie HG, Harris PA, Williams SM, Wood AJ, Stein CM.

J Hypertens. 2010 Feb;28(2):278-84. doi: 10.1097/HJH.0b013e328333d212.

14.

Acute dilation to alpha(2)-adrenoceptor antagonists uncovers dual constriction and dilation mediated by arterial alpha(2)-adrenoceptors.

Crassous PA, Flavahan S, Flavahan NA.

Br J Pharmacol. 2009 Nov;158(5):1344-55. doi: 10.1111/j.1476-5381.2009.00403.x. Epub 2009 Sep 28.

15.

Effects of nitric oxide synthase inhibition on dexmedetomidine-induced vasoconstriction in healthy human volunteers.

Snapir A, Talke P, Posti J, Huiku M, Kentala E, Scheinin M.

Br J Anaesth. 2009 Jan;102(1):38-46. doi: 10.1093/bja/aen316. Epub 2008 Nov 5.

16.

In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.

Lehtimäki J, Leino T, Koivisto A, Viitamaa T, Lehtimäki T, Haapalinna A, Kuokkanen K, Virtanen R.

Eur J Pharmacol. 2008 Dec 3;599(1-3):65-71. doi: 10.1016/j.ejphar.2008.10.003. Epub 2008 Oct 9.

PMID:
18930723
17.

Dexmedetomidine and ST-91 analgesia in the formalin model is mediated by alpha2A-adrenoceptors: a mechanism of action distinct from morphine.

Nazarian A, Christianson CA, Hua XY, Yaksh TL.

Br J Pharmacol. 2008 Dec;155(7):1117-26. doi: 10.1038/bjp.2008.341. Epub 2008 Sep 1.

18.

Dexmedetomidine enhances the local anesthetic action of lidocaine via an alpha-2A adrenoceptor.

Yoshitomi T, Kohjitani A, Maeda S, Higuchi H, Shimada M, Miyawaki T.

Anesth Analg. 2008 Jul;107(1):96-101. doi: 10.1213/ane.0b013e318176be73.

PMID:
18635472
19.

Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors.

Dahmani S, Paris A, Jannier V, Hein L, Rouelle D, Scholz J, Gressens P, Mantz J.

Anesthesiology. 2008 Mar;108(3):457-66. doi: 10.1097/ALN.0b013e318164ca81.

PMID:
18292683
20.

Alpha2-adrenoceptors enhance angiotensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA.

Jackson EK, Gillespie DG, Zhu C, Ren J, Zacharia LC, Mi Z.

Hypertension. 2008 Mar;51(3):719-26. doi: 10.1161/HYPERTENSIONAHA.107.096297. Epub 2008 Feb 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk